Document Type : case report
Authors
- Mohammad Ali Kiani 1
- Hamidreza Kianifar 1
- Sayyad Ali Jafari 2
- Maryam khalesi 2
- Niloofar Rahimpour 3
- Arefeh Abavisani 4
1 Professor of Pediatric Gastroenterology and Hepatology, Department of Pediatric Gastroenterology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Associate Professor of Pediatric Gastroenterology and Hepatology, Department of Pediatric Gastroenterology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
3 Pediatric Resident, Department of Pediatric Gastroenterology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
4 Pediatric Gastroenterology and Hepatology Fellow, Department of Pediatric Gastroenterology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract
Background: Werner syndrome (WS) is a rare autosomal recessive disorder characterized by premature aging and various metabolic complications. Non-Alcoholic Fatty Liver Disease (NAFLD) is primarily associated with metabolic syndrome, but its occurrence in young patients with WS is rarely reported. We describe the case of a 17-year-old male diagnosed with Werner syndrome who presented with grade 2 NAFLD and elevated liver function tests (LFTs).
Case Presentation: A 17-year-old male, born to consanguineous parents, presented with clinical features suggestive of premature aging. Genetic testing confirmed a mutation in the WRN gene, establishing a diagnosis of Werner syndrome. Liver ultrasound revealed grade 2 fatty liver, and liver biopsy confirmed moderate steatohepatitis (activity grade 6, stage 2). Elevated liver enzymes were observed, although other metabolic parameters were within normal limits.
Conclusion: This case highlights the importance of recognizing liver involvement in patients with Werner syndrome and underscores the need for routine monitoring and a multidisciplinary approach to management. Genetic counseling is essential for families with consanguineous backgrounds to reduce the risk of autosomal recessive conditions like WS.
Keywords
- Oshima J, Sidorova JM, Monnat Jr RJ. Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions. Ageing research reviews. 2017 Jan 1;33:105-14.
- Cj E. Werner's syndrome. A review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine. 1996;45:177.
- Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, et al. Positional cloning of the Werner's syndrome gene. Science. 1996 Apr 12;272(5259):258-62.
- Bittles AH. Consanguinity and its relevance to clinical genetics. Clinical genetics. 2001 Aug;60(2):89-98.
- Muftuoglu M, Oshima J, von Kobbe C, Cheng WH, Leistritz DF, Bohr VA. The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis. Human genetics. 2008 Nov;124:369-77.
- Huang S, Lee L, Hanson NB, Lenaerts C, Hoehn H, Poot M, et al. The spectrum of WRN mutations in Werner syndrome patients. Human mutation. 2006 Jun;27(6):558-67.
- Khan MS, Lee C, Kim SG. Non-alcoholic fatty liver disease and liver secretome. Archives of Pharmacal Research. 2022 Dec;45(12):938-63.
- Maurice J, Manousou P. Non-alcoholic fatty liver disease. Clinical medicine. 2018 Jun 1;18(3):245-50.
- Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009 Jan;13(1):9.
- Luo J. WRN protein and Werner syndrome. North American journal of medicine & science. 2010;3(4):205.
- Vancells Lujan P, Vinas Esmel E, Sacanella Meseguer E. Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development. Nutrients. 2021 Apr 24;13(5):1442.
- Raffan E, Hurst LA, Turki SA, Carpenter G, Scott C, Daly A, et al. Early diagnosis of Werner's syndrome using exome-wide sequencing in a single, atypical patient. Frontiers in Endocrinology. 2011 Mar 29;2:8.
- Nalbantoglu I, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease. World journal of gastroenterology: WJG. 2014 Jul 21;20(27):9026.
- Rossi ML, Ghosh AK, Bohr VA. Roles of Werner syndrome protein in protection of genome integrity. DNA repair. 2010 Mar 2;9(3):331-44.
- He G, Yan Z, Sun L, Lv Y, Guo W, Gang X, et al. Diabetes mellitus coexisted with progeria: a case report of atypical Werner syndrome with novel LMNA mutations and literature review. Endocrine journal. 2019;66(11):961-9.
- Dhamija E, Paul SB, Kedia S. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern. Indian Journal of Medical Research. 2019 Jan 1;149(1):9-17.
- Mavrogiannaki AN, Migdalis IN. Nonalcoholic fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. International journal of endocrinology. 2013;2013(1):450639.
- Armandi A, Rosso C, Caviglia GP, Bugianesi E. Insulin resistance across the spectrum of nonalcoholic fatty liver disease. Metabolites. 2021 Mar 8;11(3):155.
- Pagano G, Aiello Talamanca A, Castello G, Cordero MD, d’Ischia M, Gadaleta MN, et al. Oxidative stress and mitochondrial dysfunction across broad‐ranging pathologies: toward mitochondria‐targeted clinical strategies. Oxidative medicine and cellular longevity. 2014;2014(1):541230.
- Farrell GC, Van Rooyen D, Gan L, Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut and liver. 2012 Apr 17;6(2):149.
- Godoy-Matos AF, Silva Júnior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & metabolic syndrome. 2020 Dec;12:1-20.
- Banini BA, Sanyal AJ. Nonalcoholic fatty liver disease: epidemiology, pathogenesis, natural history, diagnosis, and current treatment options. Clinical Medicine Insights: Therapeutics. 2016 Jan;8:CMT-S18885.
- Keating SE, Sabag A, Hallsworth K, Hickman IJ, Macdonald GA, Stine JG, et al. Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: A position statement from exercise and sport science Australia. Sports Medicine. 2023 Dec;53(12):2347-71.
)